Abstract:Ian JY Wee, 1 Fiona NN Moe, 1 Rehena Sultana, 2 Reiko WT Ang, 1 Pearly PS Quek, 3 Brian Kim Poh Goh, 1 Chung Yip Chan, 1 Peng Chung Cheow, 1 Alexander YF Chung, 1 Prema Raj Jeyaraj, 1 Ye Xin Koh, 1 Peter OP Mack, 1 London Lucien PJ Ooi, 1 Ek Khoon Tan, 1 Jin Yao Teo, 1 Juinn Huar Kam, 1 Jacelyn SS Chua, 1 Ashley WY Ng, 1 Jade SQ Goh, 1 Pierce KH Chow 1, 4 1 Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore; 2 Center of Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore; 3 Ministry of Health Holdings, Singapore, Singapore; 4 Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore Correspondence: Pierce KH Chow, Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore, Tel +65 6576 2151, Email Objective: We aimed to prognosticate survival after surgical resection of HCC stratified by stage with amalgamation of the modified Barcelona Clinic Liver Cancer (BCLC) staging system and location of tumour. Methods: This single-institutional retrospective cohort study included patients with HCC who underwent surgical resection between 1st January 2000 to 30th June 2016. Participants were divided into 6 different subgroups: A-u) Within MC with Unilobar lesions; A-b) Within MC + Bilobar lesions; B1-u) Out of MC + within Up-To-7 + Unilobar lesions; B1-b) Out of MC + within Up-to-7 + Bilobar lesions; B2-u) Out of MC + Out of Up-To-7 + Unilobar lesions; B2-b) Out of MC + Out of Up-To-7 + Bilobar lesions. A separate survival analysis was conducted for solitary HCC lesions according to three subgroups: A-S (Within MC); B1-S (Out of MC + within Up-To-7); B2-S (Out of MC + out of Up-To-7). Results: A total of 794 of 1043 patients with surgical resection for HCC were analysed. Groups A-u (64.6%), A-b (58.4%) and B1-u (56.2%) had 5-year cumulative overall survival (OS) rates above 50% after surgical resection and median OS exceeding 60 months (P = 0.0001). The 5-year cumulative recurrence-free survival rates (RFS) were 40.4% (group A-u), 38.2% (group A-b), 36.3% (group B1-u), 24.6% (group B2-u), and 7.3% (group B2-b)(P=0.0001). For solitary lesions, the 5-year OS for the subgroups were A-S (65.1%), B1-S (56.0%) and B2-S (47.1%) (P = 0.0003). Compared to A-S, there was also a significant trend towards relatively poorer OS as the lesion sizes increased in B1-S (HR 1.46, 95% CI 1.03– 2.08) and B2-S (HR 1.65, 95% CI 1.25– 2.18). Conclusion: We adopted a novel approach combining the modified BCLC B sub-classification and dispersion of tumour to show that surgical resection in intermediate stage HCC can be robustly prognosticated. We found that size prognosticates resection outcomes in solitary tumours. Keywords: hepatocellular carcinoma, surgical resection, Barcelona clinic liver cancer Should indications for surgical resection be extended to intermediate hepatocellular carcinoma? Typically, surgical resection is offered only to patients with hepatocellular carcinomas of an early stage – called Barcelona Liver Cancer Clinic (BCLC) A. Here we adapted the BCLC classification system, showing that if you take the location of the tumour into account as well, you can cure some patients with more advanced BCLC B disease as well. Surgery can cure some patients with BCLC Sub class B1 cancers, if the cancer is confined to one lobe. It should be considered in these patients. Globally, hepatocellular carcinoma (HCC) represents the fourth most common cause of cancer-related mortality. 1 Surgical resection remains the main treatment modality in early HCC provided there is adequate liver function and sufficient future liver remnant. 2 A systematic review of 4209 patients with HCC within the Milan Criteria (MC) demonstrated median 5-year overall survival (OS) of 67% after surgical resection, which crosses 5-year OS of 50% thereby making surgical resection conceptually curative in this group of patients, 3 as first proposed by LLovet and Bruix in 1999 4 and in their subsequent update in 2002. 5 Recent evidence has however suggested that surgical resection may be justifiably offered to select individuals with intermediate- or advanced-stage disease. 6,7 While a number of staging systems have been validated for prognostic evaluation of HCC, there is no universally adopted system. Nevertheless, the Barcelon -Abstract Truncated-

Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysis

Laparoscopic Versus Open Major Hepatectomy For Hepatocellular Carcinoma: A Meta-Analysis

Surgical Resection Plus Radiofrequency Ablation Versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study

Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival.

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰

Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?

Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System

Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses

Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study

Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma

Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a retrospective analysis from a high-volume referral center

Surgery for large primary liver cancer more than 10 cm in diameter

A Multidisciplinary Therapeutic Approach Proposal for Huge Hepatocellular Carcinomas Exceeding 10 cm in Diameter

Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study

Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume

Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma